Charles Schwab Investment Management Inc Avita Medical, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Avita Medical, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 64,215 shares of RCEL stock, worth $348,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,215
Previous 70,905
9.44%
Holding current value
$348,045
Previous $907,000
42.45%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RCEL
# of Institutions
78Shares Held
6.99MCall Options Held
36.4KPut Options Held
26K-
Black Rock Inc. New York, NY1.78MShares$9.67 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$7.77 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA620KShares$3.36 Million0.0% of portfolio
-
State Street Corp Boston, MA527KShares$2.86 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA440KShares$2.38 Million0.98% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $136M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...